Relafen Relafen-750 represents the intriguing case study from a biochemical drug development perspective . Its mechanism of suppression cyclooxygenase enzymes , specifically COX-2, offers the unique method to managing discomfort. The drug's targeting for COX-2, aiming to minimize bowel complications associated with non-selective NSAIDs, undersco… Read More